276 filings
ARS
2023 FY
EVH
Evolent Health Inc - Ordinary Shares
26 Apr 24
Annual report to shareholders
4:26pm
DEFA14A
EVH
Evolent Health Inc - Ordinary Shares
26 Apr 24
Additional proxy soliciting materials
4:22pm
DEF 14A
EVH
Evolent Health Inc - Ordinary Shares
Definitive proxy
26 Apr 24
4:20pm
S-3ASR
EVH
Evolent Health Inc - Ordinary Shares
23 Feb 24
Automatic shelf registration
6:52am
10-K
2023 FY
EVH
Evolent Health Inc - Ordinary Shares
Annual report
22 Feb 24
6:09pm
8-K
3hk5jtz65gurv
22 Feb 24
Evolent Announces Fourth Quarter and Full Year 2023 Results
4:18pm
8-K
ege6cl fudf5
14 Feb 24
Evolent Adds Russell Glass, Headspace CEO, to Board of Directors
4:15pm
8-K
dimgvolbpb6o37m
8 Jan 24
Results of Operations and Financial Condition
5:00pm
8-K
e13730i5r
8 Dec 23
Entry into a Material Definitive Agreement
6:16pm
8-K
sbf6o
6 Dec 23
Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan
6:09am
8-K
lmq00ypfm55 ywcgff7
5 Dec 23
Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan
7:02am
8-K
7251rc
3 Nov 23
Other Events
8:55am
424B7
7p4 wdpgeh2y638
3 Nov 23
Prospectus with selling stockholder info
8:53am
424B7
eook5k1bf4z0f6056c8k
3 Nov 23
Prospectus with selling stockholder info
8:51am
S-8
kfgsp0g7
2 Nov 23
Registration of securities for employees
8:12pm
8-K
idws0ttp6v2y1gl
2 Nov 23
Combined Financial Statements
8:09pm
8-K
1089l362m 9cq8dz6
2 Nov 23
Evolent Announces Third Quarter 2023 Results
4:18pm
8-K/A
1oei9r
13 Oct 23
Combined Unaudited Financial Statements
5:35pm
8-K/A
icgixct
26 Sep 23
Combined Financial Statements
5:28pm